RAEGAN SWARINGEN: Open Payments
NPI 1013390574 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,893 in 121 payments from 20 companies in 2025. Trend: 2023 $1,059 · 2024 $1,763 · 2025 $2,893
Food & beverage: $2,809Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $664 |
| ABBVIE INC. | 19 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $313 |
| Gilead Sciences, Inc. | 14 | $285 |
| Phathom Pharmaceuticals, Inc. | 11 | $239 |
| Madrigal Pharmaceuticals | 7 | $164 |
| Lilly USA, LLC | 7 | $142 |
| PFIZER INC. | 7 | $131 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $126 |
| Aimmune Therapeutics, Inc. | 4 | $114 |
Products named: TREMFYA, ENTYVIO, VOQUEZNA, REZDIFFRA, SKYRIZI, OMVOH, ZENPEP, XIFAXAN.
Industry payments across NC — which companies pay providers there.
